Clinical experiences with venetoclax and other pro-apoptotic agents in lymphoid malignancies: lessons from monotherapy and chemotherapy combination

por Lew, Thomas E., Seymour, John F.
Publicado 2022

REHABILITATION IN PATIENTS WITH LYMPHOMA: AN OVERVIEW OF SYSTEMATIC REVIEWS

por AMATYA, Bhasker, KHAN, Fary, LEW, Thomas E., DICKINSON, Michael
Publicado 2021

Promises and pitfalls of targeted agents in chronic lymphocytic leukemia

por Lew, Thomas E., Anderson, Mary Ann, Seymour, John F.
Publicado 2020

Early serum creatinine accurately predicts acute kidney injury post cardiac surgery

por Grynberg, Keren, Polkinghorne, Kevan R., Ford, Sharon, Stenning, Fiona, Lew, Thomas E., Barrett, Jonathan A., Summers, Shaun A.
Publicado 2017

Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance

por Blombery, Piers, Thompson, Ella R., Lew, Thomas E., Tiong, Ing Soo, Bennett, Rory, Cheah, Chan Y., Lewis, Katharine Louise, Handunnetti, Sasanka M., Tang, Chloe Pek Sang, Roberts, Andrew, Seymour, John F., Tam, Constantine S.
Publicado 2022

Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition

por Lew, Thomas E., Lin, Victor S., Cliff, Edward R., Blombery, Piers, Thompson, Ella R., Handunnetti, Sasanka M., Westerman, David A., Kuss, Bryone J., Tam, Constantine S., Huang, David C. S., Seymour, John F., Roberts, Andrew W., Anderson, Mary Ann
Publicado 2021

Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy

por Thijssen, Rachel, Tian, Luyi, Anderson, Mary Ann, Flensburg, Christoffer, Jarratt, Andrew, Garnham, Alexandra L., Jabbari, Jafar S., Peng, Hongke, Lew, Thomas E., Teh, Charis E., Gouil, Quentin, Georgiou, Angela, Tan, Tania, Djajawi, Tirta M., Tam, Constantine S., Seymour, John F., Blombery, Piers, Gray, Daniel H.D., Majewski, Ian J., Ritchie, Matthew E., Roberts, Andrew W., Huang, David C.S.
Publicado 2022